Provided by Tiger Trade Technology Pte. Ltd.

B. Riley

4.81
+1.0929.30%
Volume:8.17M
Turnover:37.72M
Market Cap:147.17M
PE:-0.20
High:4.90
Open:4.73
Low:4.36
Close:3.72
52wk High:7.90
52wk Low:2.67
Shares:30.60M
Float Shares:16.01M
Volume Ratio:38.93
T/O Rate:51.01%
Dividend:0.50
Dividend Rate:10.39%
EPS(TTM):-24.1187
EPS(LYR):-25.4591
ROE:-3385.42%
ROA:-26.41%
PB:-0.30
PE(LYR):-0.19

Loading ...

B. Riley Adjusts Price Target on BitMine Immersion to $47 From $90, Maintains Buy Rating

MT Newswires Live
·
Nov 20

Gladstone Capital Shares Rise After Upgrades From B. Riley, Oppenheimer

MT Newswires Live
·
Nov 20

B. Riley Financial granted request to continue listing on Nasdaq

TIPRANKS
·
Nov 20

B. Riley Financial Granted Nasdaq Extension to Cure Filing Delinquencies

Reuters
·
Nov 20

Varex Imaging Price Target Maintained With a $16.00/Share by B. Riley Securities

Dow Jones
·
Nov 20

Nuvation Bio Shares Surge After B. Riley Initiates Coverage at Buy

MT Newswires Live
·
Nov 20

B. Riley Upgrades Gladstone Capital to Buy From Neutral, Adjusts Price Target to $22 From $27

MT Newswires Live
·
Nov 19

B. Riley Initiates Coverage on Nuvation Bio With Buy Rating, $12 Price Target

MT Newswires Live
·
Nov 19

Nuvation Bio initiated with a Buy at B. Riley

TIPRANKS
·
Nov 19

Gladstone Capital upgraded to Buy from Neutral at B. Riley

TIPRANKS
·
Nov 19

B Riley Financial: Q1 2025 REV $186.1 Mln, Loss per Share $0.39 - SEC Filing

THOMSON REUTERS
·
Nov 19

Press Release: B. Riley Financial Reports First Quarter 2025 Results

Dow Jones
·
Nov 19

Perspective Therapeutics Is Maintained at Buy by B. Riley Securities

Dow Jones
·
Nov 19

BitFuFu price target lowered to $6 from $7 at B. Riley

TIPRANKS
·
Nov 18

Onto Innovation price target raised to $180 from $173 at B. Riley

TIPRANKS
·
Nov 18

Tango Therapeutics price target raised to $14 from $8 at B. Riley

TIPRANKS
·
Nov 18

B. Riley Adjusts Price Target on LifeMD to $10 From $12, Maintains Buy Rating

MT Newswires Live
·
Nov 18

B. Riley Adjusts Price Target on SharpLink Gaming to $19 From $32, Maintains Buy Rating

MT Newswires Live
·
Nov 18

B. Riley Adjusts Price Target on Onto Innovation to $180 From $173, Maintains Buy Rating

MT Newswires Live
·
Nov 18

B. Riley Adjusts Price Target on Perspective Therapeutics to $11 From $12, Maintains Buy Rating

MT Newswires Live
·
Nov 18